M4MM

What Does Cannabis 3.0 Actually Mean?

LOS ANGELES- If Cannabis 1.0 was legalization and survival, and Cannabis 2.0 was scale and brand proliferation, Cannabis 3.0 is something far more structural. It is the shift from product velocity to process discipline. From ...

Organigram Strikes Deal to Acquire Sanity Group

TORONTO-BERLIN – Organigram Global Inc. has signed a definitive agreement to purchase the remaining shares of Berlin-based Sanity Group GmbH that it does not already hold. The transaction builds on Organigram's earlier minority stake and ...

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

What Does Cannabis 3.0 Actually Mean?

LOS ANGELES- If Cannabis 1.0 was legalization and survival, and Cannabis 2.0 was scale and brand proliferation, Cannabis 3.0 is something far more structural. It is the shift from product velocity to process discipline. From ...

Organigram Strikes Deal to Acquire Sanity Group

TORONTO-BERLIN – Organigram Global Inc. has signed a definitive agreement to purchase the remaining shares of Berlin-based Sanity Group GmbH that it does not already hold. The transaction builds on Organigram's earlier minority stake and ...

Medical Cannabis: Growth and Investment in 2024

LOS ANGELES- The medical cannabis industry is navigating 2024 with key players like Grow Group and Somai Pharmaceuticals leveraging new regulations and market dynamics to achieve ambitious growth targets. This article examines the recent developments ...

Constellation Brands: Analysts Maintain Ratings

LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands (NYSE: STZ), maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal ...

Critics Slam Thai Government’s Approach to Cannabis

LOS ANGELES- Critics have strongly opposed the Thai government's plan to reclassify cannabis as a narcotic, arguing that it will harm businesses involved in cannabis-based products and undermine investor confidence in the country. On July ...

Subscribe To Our Newsletter